Related Experiment Video
Updated: Jul 16, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional
Reiko Hayashi1, Yuya Goto, Ryuji Ikeda
1Laboratory of Molecular and Cellular Biology, Department of Life Sciences, School of Agriculture, Meiji University, 1-1-1 Higashimita, Kawasaki, Kanagawa 214-8571, Japan.
Abstract:
The TRIP-Br1/p34(SEI-1) family proteins participate in cell cycle progression by coactivating E2F1- or p53-dependent transcriptional activation. Here, we report the identification of human CDCA4 (also know as SEI-3/Hepp) as a novel target gene of transcription factor E2F and as a repressor of E2F-dependent transcriptional activation. Analysis of CDCA4 promoter constructs showed that an E2F-responsive sequence in the vicinity of the transcription initiation site is necessary for the E2F1-4-induced activation of CDCA4 gene transcription. Chromatin immunoprecipitation analysis demonstrated that E2F1 and E2F4 bound to an E2F-responsive sequence of the human CDCA4 gene. Like TRIP-Br1/p34(SEI-1) and TRIP-Br2 (SEI-2), the transactivation domain of CDCA4 was mapped within C-terminal acidic region 175-241. The transactivation function of the CDCA4 protein was inhibited by E2F1-4 and DP2, but not by E2F5-8. Inhibition of CDCA4 transactivation activity by E2F1 partially interfered with retinoblastoma protein overexpression. Conversely, CDCA4 suppressed E2F1-3-induced reporter activity. CDCA4 (but not acidic region-deleted CDCA4) suppressed E2F1-regulated gene promoter activity. These findings suggest that the CDCA4 protein functions as a suppressor at the E2F-responsive promoter. Small interfering RNA-mediated knockdown of CDCA4 expression in cancer cells resulted in up-regulation of cell growth rates and DNA synthesis. The CDCA4 protein was detected in several human cells and was induced as cells entered the G1/S phase of the cell cycle. Taken together, our results suggest that CDCA4 participates in the regulation of cell proliferation, mainly through the E2F/retinoblastoma protein pathway.
Insights
Cell division cycle protein 4 (CDCA4) acts as a repressor in the E2F pathway, regulating cell proliferation and DNA synthesis. Its knockdown accelerates cancer cell growth, highlighting its role in cell cycle control.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The TRIP-Br family proteins regulate cell cycle progression by coactivating E2F or p53.
- The E2F transcription factor family plays a crucial role in cell cycle control.
Purpose of the Study:
- To identify novel E2F target genes.
- To characterize the function of CDCA4 (SEI-3/Hepp) in the E2F pathway and cell proliferation.
Main Methods:
- Promoter analysis of CDCA4 gene constructs.
- Chromatin immunoprecipitation (ChIP) assays to detect E2F binding.
- Site-directed mutagenesis to map the transactivation domain.
- Small interfering RNA (siRNA) to knockdown CDCA4 expression.
- Reporter gene assays to assess transcriptional activity.
Main Results:
- CDCA4 is a novel E2F target gene, with E2F1 and E2F4 binding to its promoter.
- CDCA4 functions as a repressor of E2F-dependent transcription, particularly through its C-terminal acidic region.
- CDCA4 inhibits E2F-mediated transactivation and interferes with retinoblastoma protein function.
- CDCA4 knockdown in cancer cells increases cell growth rates and DNA synthesis.
- CDCA4 expression is induced during the G1/S phase transition.
Conclusions:
- CDCA4 is a crucial suppressor in the E2F/retinoblastoma protein pathway, regulating cell proliferation.
- CDCA4 plays a significant role in controlling cell cycle progression and DNA synthesis.
Related Concept Videos
Positive Regulator Molecules
Master Transcription Regulators
Positive Regulator Molecules
Inhibition of Cdk Activity
MAPK Signaling Cascades
Inhibition of CDK Activity

